SURVYR

TRXB New listing

TRex Bio, Inc.
IPO · listed Oct 9, 2026
$14.44
−$0.36 (2.43%)Oct 20 close
Healthcare CompareTechnicals
1M3M6M1Y2Y
-4%-1%+1%+3%+6%Oct 9Oct 20Oct 14
TRXBSPY
Wall St. Highest PT $19.73 (+36.6%) Wall St. Avg PT $16.17 (+12.0%)
$14$15$17$19$20POC $14Hi $20Avg $16
Underwater Drawdown %Max DD -3.8%Current -2.4%
0.0%-3.8%
Relative Strength vs SPY+4.4% vs SPYOutperforming
+8%0%-8%
1W
+$0.84 (6.18%)
1M
–
3M
–
6M
–
YTD
–
1Y
–

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street & Morningstar coverage
Wall Street consensusNo covering analysts on file for TRXB
Analyst price targetsNo target range on file
Morningstar star ratingNot rated
Checked Wall Street & Morningstar feeds · All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$396.3M
52-week range$13.21 – $15.50
Dividend yieldNo dividend

What they do

TRex Bio, Inc. develops immunoregulatory biologics for autoimmune and inflammatory diseases in United States and Internationally. The company operates the Deep Biology Platform, a drug discovery and design platform that integrates tissue-level insights into human biology and treg function to identify and characterize therapeutic targets, using computational mapping.

Healthcare · Biotechnology
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for TRXB yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

TRXB earningsNo upcoming date on file
Source: Yahoo Finance · refreshed 2026-10-21 01:31:10 ET
No EPS history available.

News & catalysts

More news
TRexBio Announces Closing of Initial Public Offering
GlobeNewswire · Oct 13
How to Play TRXB Stock After the TRex Bio IPO
Barchart · Oct 13
TRexBio Announces Pricing of Initial Public Offering
GlobeNewswire · Oct 08

Stats refreshed 2026-10-21 01:31:10 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026